Frequent mutations of lysophosphatidic acid receptor-1 gene in rat liver tumors

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 660, Issue 1-2, 2009, Pages 47-50

  Obo, Yumi ^a   Yamada, Takanori ^a   Furukawa, Mami ^a   Hotta, Mayuko ^a   Honoki, Kanya ^b   Fukushima, Nobuyuki ^c   Tsujiuchi, Toshifumi ^a  

^a Faculty of Science and Engineering   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c KINKI UNIVERSITY   (Japan)

Author keywords

Hepatocellular carcinoma; Lysophosphatidic acid receptor 1; Mutation; Rat

Indexed keywords

CHOLINE; DIETHYLNITROSAMINE; G PROTEIN COUPLED RECEPTOR; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR 1; LYSOPHOSPHATIDIC ACID RECEPTOR 2; LYSOPHOSPHATIDIC ACID RECEPTOR 3; LYSOPHOSPHATIDIC ACID RECEPTOR 4; LYSOPHOSPHATIDIC ACID RECEPTOR 5; RNA; UNCLASSIFIED DRUG;

AMINO ACID DEFICIENCY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; DIET RESTRICTION; LIVER CANCER; LIVER CELL CARCINOMA; LPA1 GENE; MALE; MISSENSE MUTATION; MUTATOR GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

ANIMALS; DNA MUTATIONAL ANALYSIS; LIVER NEOPLASMS; MALE; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RATS; RECEPTORS, LYSOPHOSPHATIDIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

RATTUS;

EID: 58149463915     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2008.10.005     Document Type: Article

References (31)

1. Contos J.J.A., Ishii I., and Chun J. Lysophosphatidic acid receptors. Mol. Pharmacol. 58 (2000) 1188-1196
2. Furui T., LaPushin R., Mao M., Khan H., Watt S.R., and Watt M.A.V. Overexpression of Edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophatidic acid-independent manner. Clin. Cancer Res. 5 (1999) 4308-4318
3. Goetzl E.J., Dolezalova H., Kong Y., Hu Y.L., Jaffe R.B., Kalli K.R., and Conover C.A. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer. Cancer Res. 59 (1999) 5370-5375
4. Contos J.J.A., Fukushima N., Weiner J.A., Kaushal D., and Chun J. Requirement for the lpA1 lysophosohatidic acid receptor gene in normal suckling behavior. Proc. Natl. Acad. Sci. USA 97 (2000) 13383-13389
5. Contos J.J.J.A., Ishii I., Fukushima N., Kingsbury M.A., Ye X., Kawamura S., Brown J.H., and Chun J. Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysopfosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2). Mol. Cell. Biol. 22 (2002) 6921-6929
6. Fang X., Schummer M., Mao M., Yu S., Tabassam F.H., Swaby R., Hasegawa Y., Tanyi J.L., LaPushin R., Eder A., Jaffe R., Erickson J., and Mills G.B. Lysophosphatidic acid is a bioactive mediator in ovarian cancer. Biochim. Biophys. Acta 1582 (2002) 257-264
7. Fujita T., Miyamoto S., Onoyama I., Sonoda K., Mekada E., and Nakano H. Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer. Cancer Lett. 192 (2003) 161-169
8. An S., Bleu T., Halmark O.G., and Goetzl E.J. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J. Biol. Chem. 273 (1998) 7906-7910
9. Bandoh K., Aoki J., Hosono H., Kobayashi S., and Kobayashi T. K molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J. Biol. Chem. 274 (1999) 27776-27785
10. Noguchi K., Ishii S., and Shimizu T. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J. Biol. Chem. 278 (2003) 25600-25606
11. Lee C.W., Rivera R., Gardell S., Dubin A.E., and Chun J. GPR92 as a new G12/13 and Gq coupled lysophosphatidic acid receptor that increases cAMP: LPA5. J. Biol. Chem. 281 (2006) 23589-23597
12. Shida D., Watanabe T., Aoki J., Hama K., Kitayama J., Sonoda H., Kishi Y., Yamaguchi H., Sasaki S., Sako A., Konishi T., Arai H., and Nagawa H. Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer. Lab. Invest. 84 (2004) 1352-1362
13. Tsujiuchi T., Shimizu K., Onishi M., Shigemura M., Shano S., Honoki K., and Fukushima N. Aberrant expressions of lysophosphatidic acid receptor genes in lung and liver tumors of rats. J. Toxicol. Pathol. 19 (2006) 137-141
14. Tsujiuchi T., Shimizu K., Onishi M., Sugata E., Fujii H., Mori T., Honoki K., and Fukushima N. Involvement of aberrant DNA methylation on reduced expression of lysophosphatidic acid receptor-1 gene in rat tumor cell lines. Biochem. Biophys. Res. Commun. 349 (2006) 1151-1155
15. Ohashi K., Tsutsumi M., Tsujiuchi T., Kobitsu K., Okajima E., Nakajima Y., Nakano H., Takahama M., Mori Y., and Konishi Y. Enhancement of N-nitrosodiethylamine-initiated hepatocarcinogenesis caused by a colchicines-induced cell cycle disturbance in partially hepatecomized rats. Cancer Res. 56 (1996) 3473-3479
16. Tsutsumi M., Ohashi K., Tsujiuchi T., Kobayashi E., Kobitsu K., Kitada H., Majima T., Okajima E., Endoh T., Hasegawa K., Mori T., and Konishi Y. Disturbance of the cell cycle with colchicines enhances the growth advantage of diethylnitrosamine-initiatednhepatocytes in rats. Jpn. J. Cancer Res. 87 (1996) 5-9
17. Nakae D., Yoshiji H., Mizumoto Y., Horiguchi K., Shiraiwa K., Tamura K., Denda A., and Konishi Y. High incidence of hepatocellular carcinomas induced by a choline deficient l-amino acid defined diet in rats. Cancer Res. 52 (1992) 5042-5054
18. Kobayashi Y., Nakae D., Akai H., Kishida H., Okajima E., Kitayama W., Denda A., Tsujiuchi T., Murakami A., Koshimizu K., Ohigashi H., and Konishi Y. Prevention by 1′-acetixychavicol acetate of the induction but not growth of putative preneoplastic, glutathione S-transferase placental form-positive, focal lesions in the livers of the rats fed choline deficient l-amino acid defined diet in rats. Carcinogenesis 19 (1998) 1809-1814
19. Tsujiuchi T., Tsutsumi M., Sasaki Y., Takahama M., and Konishi Y. Different frequencies and patterns of β-catenin mutations in hepatocellular carcinomas induced by N-nitrosodiethylamine and a choline deficient l-amino acid defined diet in rats. Cancer Res. 59 (1999) 3904-3907
20. Higgins G.M., and Anderson R.M. Experimental pathology of the liver. 1. Restoration of the liver of the white rat following partial surgical removal. Arch. Pathol. Lab. Med. 12 (1931) 1186-1202
21. Cayama E., Tsuda H., Sarma D.S.R., and Farber E. Initiation of chemical carcinogenesis requires cell proliferation. Nature (Lond.) 275 (1978) 60-62
22. Shano S., Hatanaka K., Ninose S., Moriyama R., Tsujiuchi T., and Fukushima N. A lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation. Biochim. Biophys. Acta. 1783 (2008) 748-759
23. Jiao J., Pienkowska M., Glickman B.W., and Zielenska M. Molecular analysis of mutations induced by ethylationg N-nitroso compounds in the lacI gene of Escherichia coli. Mutat. Res. 352 (1996) 39-45
24. Kitada H., Tsutsumi M., Tsujiuchi T., Takahama M., Fukuda T., Narita N., and Konishi Y. Frequent mutations of Ki-ras but no mutations of Ha-ras and p53 in lung lesions induced N-nitrosobis(2-hydroxypropyl) amine by in rat. Mol. Carcinog. 115 (1996) 276-283
25. Tsutsumi M., Murakami Y., Kondoh S., Tsujiuchi T., Honoki K., Horiguchi K., Noguchi O., Kobayashi E., Okita S., Sekiya T., and Konishi Y. Comparison of K-ras oncogene activation in pancreatic duct carcinomas and cholangiocarcinomas induced in hamsters by N-nitrosobis(2-oxopropyl)amine. Jpn. J. Cancer Res. 84 (1993) 956-960
26. Nakae D., Yoshiji H., Maruyama H., Kinugasa T., Denda A., and Konishi Y. Production of both 8-hydroxydeoxyguanosine in liver DNA and γ-glutamyltransferase-positive hepatocellular lesions in rat given a choline-deficient, l-amino acid-defined diet. Jpn. J. Cancer Res. 81 (1990) 1081-1084
27. Moriya M., Ou C., Bodepudi V., Johnson F., Takeshita M., and Grollma A.P. Site-specific mutagenesis using a gapped duplex vector: a study of translation synthesis past 8-oxodeoxyguanosine in E. coli. Mutat. Res. 254 (1991) 281-288
28. Malins D.C., and Haimanot R. 4,6-Diamino-5-formamidopyrimidine, 8-hydroxyguanine and 8-hydroxyadenine in DNA from neoplastic liver of English sole exposed to carcinogens. Biochem. Biophys. Res. Commun. 173 (1990) 614-619
29. Kamiya H., Miura H., Murata-Kamiya N., Ishikawa H., Sakaguchi T., Inoue H., Sasaki T., Masutani C., Hanaoka F., and Nishimura S. 8-Hydroxyadenine (7,8-dihydro-8-oxoadenine) induces misincorporation in in vitro DNA synthesis and mutations in NIH3T3 cells. Nucl. Acids Res. 23 (1995) 2893-2899
30. Wang D., Kreutzer D.A., and Essigmann J.M. Mutagenicity and repair of oxidative DNA damage: insights from studies using defined lesions. Mutat. Res. 400 (1998) 99-115
31. Sasaki Y., Tsujiuchi T., Murata N., Tsutsumi M., and Konishi Y. Alterations of the transforming growth factor-β signaling pathway in hepatocellular carcinomas induced by endogenously and exogenously in rats. Jpn. J. Cancer Res. 92 (2001) 16-22